Antacid Market is valued approximately USD 6.13 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 3.9% over the forecast period 2019-2026. The growingincrease prevalence of gastric diseases has led the healthcare and pharmaceuticals providers towards the development of more enhanced gastric solution to get relief from acidity and heartburns. Antacids are the class of drugs thatwhich reduces gastric acidity resulting in the increase pH of the stomach and duodenum. The growing prevalence of gastric diseases among geriatric population has led to the increase in demand for antacids. The advancement of e-commerce industry coupled with the consumer preference for online medication due to ease of availability of drugs and home delivery services has propelled the demand for antacids. The increasing adoption of self-medication and ease of availability of various over-the-counter antacids has increased the market share of antacids. Moreover, the population of Gastroesophageal reflux disease, or GERD, has increased significantly resulting in the growingincreased demand for antacids. The various factors leading to the gastric diseases are unhealthy diet, lack of proper sleep, and lack of physical activities. This hasve resulted in the accelerated market share of antacids.
The regional analysis of Antacid market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia Pacific region is expected to register considerable growth over the forecast period owing to consumer awareness, rising investment by market players and growing disposable income have increased the market share of antacids. Moreover, availability of effective treatment methods has fostered the demand for antacids.
Major market player included in this report are:
GlaxoSmithKline plc
Bayer AG
Boehringer Ingelheim International GmbH
Sanofi
Pfizer Inc.
Abbott Laboratories
Dabur India Ltd.
GlaxoSmithKline plc
Sun Pharmaceuticals Ltd.
Procter & Gamble
Piramal Enterprises
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.
The detailed segments and sub-segment of the market are explained below:
By Drug Class:
H2 Antagonist
Proton pump inhibitors
Acid neutralizers
By Formulation:
Tablet
Liquid
Powder
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Antacid Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors"
Interested in this report?
Get your sample now!
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1. Antacid Market, by Region, 2017-2026 (USD Billion)
1.2.2. Antacid Market, by Drug Class, 2017-2026 (USD Billion)
1.2.3. Antacid Market, by Formulation, 2017-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Antacid Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Antacid Market Dynamics
3.1. Antacid Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Antacid Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Antacid Market, by Drug Class
5.1. Market Snapshot
5.2. Antacid Market by Drug Class, Performance - Potential Analysis
5.3. Antacid Market Estimates & Forecasts by Drug Class 2016-2026 (USD Billion)
5.4. Polymer Emulsion Market, Sub Segment Analysis
5.4.1. H2 Antagonist
5.4.2. Proton pump inhibitors
5.4.3. Acid neutralizers
Chapter 6. Antacid Market, by Formulation
6.1. Market Snapshot
6.2. Antacid Market by Formulation, Performance - Potential Analysis
6.3. Antacid Market Estimates & Forecasts by Formulation 2016-2026 (USD Billion)
6.4. Polymer Emulsion Market, Sub Segment Analysis
6.4.1. Tablet
6.4.2. Liquid
6.4.3. Powder
Chapter 7. Antacid Market, Regional Analysis
7.1. Antacid Market, Regional Market Snapshot
7.2. North America Antacid Market
7.2.1. U.S. Antacid Market
7.2.1.1. Drug Class breakdown estimates & forecasts, 2016-2026
7.2.1.2. Formulation breakdown estimates & forecasts, 2016-2026
7.2.2. Canada Antacid Market
7.3. Europe Antacid Market Snapshot
7.3.1. U.K. Antacid Market
7.3.2. Rest of Europe Antacid Market
7.4. Asia-Pacific Antacid Market Snapshot
7.4.1. China Antacid Market
7.4.2. India Antacid Market
7.4.3. Japan Antacid Market
7.4.4. Rest of Asia Pacific Antacid Market
7.5. Latin America Antacid Market Snapshot
7.5.1. Brazil Antacid Market
7.5.2. Mexico Antacid Market
7.6. Rest of The World Antacid Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. GlaxoSmithKline plc
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Bayer AG
8.2.3. Boehringer Ingelheim International GmbH
8.2.4. Sanofi
8.2.5. Pfizer Inc.
8.2.6. Abbott Laboratories
8.2.7. Dabur India Ltd.
8.2.8. GlaxoSmithKline plc
8.2.9. Sun Pharmaceuticals Ltd.
8.2.10. Procter & Gamble
8.2.11. Piramal Enterprises
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF ANTACID MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF ANTACID MARKET
TABLE 3. ANTACID MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. ANTACID MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. ANTACID MARKET ESTIMATES & FORECASTS BY DRUG CLASS 2016-2026 (USD BILLION)
TABLE 8. ANTACID MARKET ESTIMATES & FORECASTS BY FORMULATION 2016-2026 (USD BILLION)
TABLE 9. ANTACID MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 10. ANTACID MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 11. ANTACID MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. ANTACID MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. ANTACID MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. ANTACID MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. ANTACID MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. ANTACID MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. ANTACID MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. ANTACID MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. U.S. ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. U.S. ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 21. U.S. ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 22. CANADA ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 23. CANADA ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 24. CANADA ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 25. UK ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 26. UK ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 27. UK ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 28. GERMANY ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 29. GERMANY ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 30. GERMANY ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 31. ROE ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 32. ROE ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 33. ROE ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 34. CHINA ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 35. CHINA ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 36. CHINA ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 37. INDIA ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 38. INDIA ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 39. INDIA ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 40. JAPAN ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 41. JAPAN ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 42. JAPAN ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 43. ROAPAC ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 44. ROAPAC ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 45. ROAPAC ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 46. BRAZIL ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 47. BRAZIL ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 48. BRAZIL ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 49. MEXICO ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 50. MEXICO ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 51. MEXICO ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 52. ROLA ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 53. ROLA ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 54. ROLA ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 55. ROW ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 56. ROW ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 57. ROW ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
FIG 1. ANTACID MARKET, RESEARCH METHODOLOGY
FIG 2. ANTACID MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. ANTACID MARKET, KEY TRENDS 2018
FIG 5. ANTACID MARKET, GROWTH PROSPECTS 2019-2026
FIG 6. ANTACID MARKET, PORTERS 5 FORCE MODEL
FIG 7. ANTACID MARKET, PEST ANALYSIS
FIG 8. ANTACID MARKET, VALUE CHAIN ANALYSIS
FIG 9. ANTACID MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 10. ANTACID MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 11. ANTACID MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 12. ANTACID MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 13. ANTACID MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 14. ANTACID MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 15. NORTH AMERICA ANTACID MARKET 2016 & 2026 (USD BILLION)
FIG 16. EUROPE ANTACID MARKET 2016 & 2026 (USD BILLION)
FIG 17. ASIA PACIFIC ANTACID MARKET 2016 & 2026 (USD BILLION)
FIG 18. LATIN AMERICA ANTACID MARKET 2016 & 2026 (USD BILLION)
FIG 19. ANTACID MARKET, COMPANY MARKET SHARE ANALYSIS (2018)
